申请人:Hoffmann-La Roche Inc.
公开号:US08063098B2
公开(公告)日:2011-11-22
The present invention relates to a compound of formula I
wherein
R1, R2, X, Ar1 and Ar2 are as defined herein and to pharmaceutically acceptable acid addition salts, to a racemic mixtures, or to their corresponding enantiomers and/or optical isomers thereof. Compounds of the invention are good inhibitors of the glycine transporter 1 (GlyT-1), and have a good selectivity to glycine transporter 2 (GlyT-2) inhibitors.
本发明涉及式I的化合物,其中R1,R2,X,Ar1和Ar2如本文所定义,并涉及药物可接受的酸加盐、外消旋混合物或其对应的对映体和/或光学异构体。本发明的化合物是良好的甘氨酸转运体1(GlyT-1)抑制剂,并具有良好的选择性对甘氨酸转运体2(GlyT-2)抑制剂。